Elevated Plasma Bioactive Adrenomedullin and Mortality in Cardiogenic Shock: Results from the OptimaCC Trial.

Koji TakagiBruno LevyAntoine KimmounÒscar MiróKévin DuarteAyu Asakage Alice Blet Benjamin Deniau Janin SchulteOliver HartmannGad CotterBeth A DavisonEtienne GayatAlexandre Mebazaa

Published in: Journal of clinical medicine (2021)

In CS patients, the values of bio-ADM are associated with some parameters of organ injury and functional impairment and are prognostic for the occurrence of refractory CS and 30-day mortality.

Keyphrases

end stage renal disease
cardiovascular events
ejection fraction
newly diagnosed
risk assessment
clinical trial
risk factors
peritoneal dialysis
prognostic factors
study protocol
type diabetes
cardiovascular disease
patient reported